PharmacoEconomics invites the submission of papers (original research, reviews and opinion pieces) on improving transparency in decision models for a themed issue of the journal to be published in 2019 and guest edited by Paul Tappenden (University of Sheffield) and Jaime Caro (London School of Economics and McGill University). We encourage papers from the perspectives of a variety of stakeholders including methodologists, payers, health technology assessment bodies, analysts, pharmaceutical industry, advocacy groups and software developers. Country-specific perspectives are also encouraged. Papers can be either methodological or applied. Continue reading “Call for Papers: Themed Issue – Improving Transparency in Decision Models”
Applied Health Economics and Health Policy invites the submission of manuscripts with a focus on the economics of mental health for a special issue of the journal to be published in 2019.
Impact Factor: 1.89
Estimates suggest that the annual cost of mental illness to developed countries is around 4% of GDP and results in around 12 million days of reduced productivity each year. To further our understanding of these issues, Applied Health Economics and Health Policy is calling for papers that explore the economic dimensions of mental health. Some key questions this work may consider include:
- Are resources allocated efficiently in mental health?
- What is the economic cost of mental illness?
- What would be the return on investment of a scaled-up response to the burden of mental ill health?
The Guest Editors for the special issue are Professor Chris Doran and Dr Irina Kinchin from Central Queensland University, Australia.
Please submit an abstract describing your proposed paper by 30 September 2018 to the Editor, Tim Wrightson. Full papers will be invited by 31 October 2018 with manuscripts due in March 2019.
By Tim Wrightson, Editor, Applied Health Economics and Health Policy
The latest issue of Applied Health Economics and Health Policy includes three articles that contribute to the literature on the relationship between out-of-pocket (OOP) payments and the accessibility and affordability of healthcare. Continue reading “Out-of-Pocket Payments for Healthcare”
Chris Carswell, Co-Editor in Chief, PharmacoEconomics
I am not a frequent blogger but one recurring issue has forced me to put finger to keyboard – insufficient detail and transparency in many submitted cost effectiveness analyses. Reporting checklists have been available for many years. According to Web of Science, the 1996 Drummond checklist has been cited over 950 times. CHEERS, published in 2013, has been cited over 260 times and is one of the most downloaded Task Force Reports from the International Society of Pharmacoeconomics and Outcomes Research. In addition, authors continue to identify the need for reporting improvement to aid transparency and facilitate model replication. So, why the apparent lack of compliance with well-recognized reporting checklists? Continue reading “Reporting Cost Effectiveness Analyses: Time for Improvement”
The open access journal Drugs in R&D was recently included in Clarivate Analytics’ Emerging Sources Citation Index (ESCI). The ESCI only considers journals that are peer reviewed, have ethical publishing practices, meet technical requirements, have English language bibliographic information, and be recommended or requested by a scholarly audience of Web of Science users.
The ESCI was launched in 2015 and citations from the ESCI will be included in the citation counts for the Journal Citation Reports that contribute to the Impact Factors of other journals. Journals in the ESCI will be discoverable via the Web of Science with an identical indexing process to other indexed journals, including citation counts and author information. Articles in ESCI indexed journals will also be included in an author’s H-Index calculation and analyses conducted with Web of Science data and related products such as InCites.
Inclusion in ESCI will improve the visibility of a journal and provides a mark of quality which should encourage submissions from authors
Professor Simon Eckermann recently launched his book Health Economics from Theory to Practice: Optimally Informing Joint Decisions of Research, Reimbursement and Regulation with Health System Budget Constraints and Community Objectives. Now, a related interview with Professor Eckermann has been broadcast on National Radio’s Health Report. This reflects the fact that, although it is a high-level academic book aimed at specialist audiences, the application of health economics is relevant to the general population. The book provides a robust set of health economic principles and methods to inform societal decisions in relation to research, reimbursement and regulation (pricing and monitoring of performance in practice). The recent launch of the book involved a public policy lecture entitled “Successful baby boomer ageing with budget constraints: where should baby boomer ageing be heading”.